ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New targeted therapy promises strong response rate across 17 cancer types
June 06, 2017Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, with its latest trial results showing that it could be the first targeted, oral, tumour-type agnostic treatment able to p
Pharma Sources Insight January 2025
